| Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model X Forns, S Ampurdanes, JM Llovet, J Aponte, L Quintó, E Martınez-Bauer, ... Hepatology 36 (4), 986-992, 2002 | 1531 | 2002 |
| Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis J Bruix, X Calvet, J Costa, M Ventura, M Bruguera, R Castillo, JM Barrera, ... The Lancet 334 (8670), 1004-1006, 1989 | 931 | 1989 |
| Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3 S Zeuzem, R Hultcrantz, M Bourliere, T Goeser, P Marcellin, ... Journal of hepatology 40 (6), 993-999, 2004 | 642 | 2004 |
| Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients JM Sánchez-Tapias, J Costa, A Mas, M Bruguera, J Rodés Gastroenterology 123 (6), 1848-1856, 2002 | 635 | 2002 |
| Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B G Fattovich, G Giustina, SW Schalm, S Hadziyannis, J Sanchez-Tapias, ... Hepatology 21 (1), 77-82, 1995 | 582 | 1995 |
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients M Laguno, J Murillas, JL Blanco, E Martínez, R Miquel, ... Aids 18 (13), 27-36, 2004 | 510 | 2004 |
| Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment JM Sánchez–Tapias, M Diago, P Escartín, J Enríquez, M Romero–Gómez, ... Gastroenterology 131 (2), 451-460, 2006 | 473 | 2006 |
| Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study G Realdi, G Fattovich, S Hadziyannis, SW Schalm, P Almasio, ... Journal of hepatology 21 (4), 656-666, 1994 | 377 | 1994 |
| Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases R Pérez-Alvarez, C Díaz-Lagares, F García-Hernández, L Lopez-Roses, ... Medicine 90 (6), 359-371, 2011 | 339 | 2011 |
| Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation A Sánchez‐Fueyo, A Rimola, L Grande, J Costa, A Mas, M Navasa, ... Hepatology 31 (2), 496-501, 2000 | 295 | 2000 |
| Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis G Fattovich, G Giustina, J Sanchez-Tapias, C Quero, A Mas, PG Olivotto, ... Official journal of the American College of Gastroenterology| ACG 93 (6 …, 1998 | 242 | 1998 |
| Hepatitis C virus infection mimicking primary Sjögren syndrome: a clinical and immunologic description of 35 cases M RAMOS-CASALS, M GARCÍA-CARRASCO, R CERVERA, J ROSAS, ... Medicine 80 (1), 1-8, 2001 | 232 | 2001 |
| Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases M Ramos-Casals, J Mañá, N Nardi, P Brito-Zerón, A Xaubet, ... Medicine 84 (2), 69-80, 2005 | 206 | 2005 |
| Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry) M Ramos-Casals, S Muñoz, F Medina, LJ Jara, J Rosas, J Calvo-Alen, ... The Journal of Rheumatology 36 (7), 1442-1448, 2009 | 178 | 2009 |
| Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft1 A Sánchez-Fueyo, JC Restrepo, L Quintó, M Bruguera, L Grande, ... Transplantation 73 (1), 56-63, 2002 | 173 | 2002 |
| Hospital admission is a relevant source of hepatitis C virus acquisition in Spain E Martínez-Bauer, X Forns, M Armelles, R Planas, R Solà, M Vergara, ... Journal of hepatology 48 (1), 20-27, 2008 | 158 | 2008 |
| Virologic, clinical, and immune response outcomes of patients with hepatitis C virus–associated cryoglobulinemia treated with direct-acting antivirals M Bonacci, S Lens, MC Londoño, Z Mariño, MC Cid, M Ramos-Casals, ... Clinical Gastroenterology and Hepatology 15 (4), 575-583. e1, 2017 | 157 | 2017 |
| Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients M Laguno, C Cifuentes, J Murillas, S Veloso, M Larrousse, A Payeras, ... Hepatology 49 (1), 22-31, 2009 | 146 | 2009 |
| Hepatitis C virus infection in patients with nonalcoholic chronic liver disease JM Sánchez-Tapias, JM Barrera, J Costa, MÍG Ercilla, A Parés, ... Annals of Internal Medicine 112 (12), 921-924, 1990 | 145 | 1990 |
| The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus JC Sáiz, FX López-Labrador, S Ampurdanés, J Dopazo, X Forns, ... Journal of Infectious Diseases 177 (4), 839-847, 1998 | 137 | 1998 |
